| pubmed-article:7052161 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7052161 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:7052161 | lifeskim:mentions | umls-concept:C0149615 | lld:lifeskim |
| pubmed-article:7052161 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:7052161 | lifeskim:mentions | umls-concept:C0457345 | lld:lifeskim |
| pubmed-article:7052161 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7052161 | pubmed:dateCreated | 1982-12-3 | lld:pubmed |
| pubmed-article:7052161 | pubmed:abstractText | Eight patients with Ph1-positive chronic myelogenous leukemia (CML) in chronic or accelerated phase received high-dose cyclophosphamide, total body irradiation, and bone marrow transplantation from an HLA-identical sibling donor. All patients had prompt engraftment and achieved complete hematologic remission. Six patients remain alive and in continuous remission with a normal bone marrow karyotype 3-20+ mo posttransplant. One patient died from cytomegalovirus interstitial pneumonitis. Only one patient who was transplanted in accelerated phase relapsed 6.5 mo posttransplant and died in blast crisis. High-dose combined modality therapy is capable of producing sustained complete remissions in patients with CML treated during chronic or accelerated phase. | lld:pubmed |
| pubmed-article:7052161 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052161 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052161 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052161 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7052161 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052161 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7052161 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052161 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7052161 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7052161 | pubmed:issn | 0006-4971 | lld:pubmed |
| pubmed-article:7052161 | pubmed:author | pubmed-author:GaleR PRP | lld:pubmed |
| pubmed-article:7052161 | pubmed:author | pubmed-author:ChamplinRR | lld:pubmed |
| pubmed-article:7052161 | pubmed:author | pubmed-author:HoWW | lld:pubmed |
| pubmed-article:7052161 | pubmed:author | pubmed-author:ArensonEE | lld:pubmed |
| pubmed-article:7052161 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7052161 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:7052161 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7052161 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7052161 | pubmed:pagination | 1038-41 | lld:pubmed |
| pubmed-article:7052161 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:meshHeading | pubmed-meshheading:7052161-... | lld:pubmed |
| pubmed-article:7052161 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:7052161 | pubmed:articleTitle | Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase. | lld:pubmed |
| pubmed-article:7052161 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7052161 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7052161 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7052161 | lld:pubmed |
